Cargando…
Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: A systematic review and meta-analysis
BACKGROUND: Although hyperthermic intraperitoneal chemotherapy (HIPEC) has been widely used to treat malignant ascites or as a preventive strategy for microscopic carcinomatosis following surgical resection of abdominal tumors, application of hyperthermic intrathoracic chemotherapy (HITHOC) in the t...
Autores principales: | Zhou, Hua, Wu, Wei, Tang, Xiaoping, Zhou, Jianying, Shen, Yihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228654/ https://www.ncbi.nlm.nih.gov/pubmed/28072694 http://dx.doi.org/10.1097/MD.0000000000005532 |
Ejemplares similares
-
Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma
por: Migliore, Marcello, et al.
Publicado: (2021) -
Present and future of hyperthermic intrathoracic chemotherapy (HITHOC) in thoracic surgical oncology
por: Migliore, Marcello
Publicado: (2021) -
Hyperthermic intrathoracic chemotherapy (HITHOC): narrative review of the current literature, recommendations and future studies
por: Markowiak, Till, et al.
Publicado: (2021) -
Intrathoracic gas effusions in patients with COVID-19
por: El Bozouiki, Fatima, et al.
Publicado: (2023) -
Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion
por: Verma, Akash, et al.
Publicado: (2016)